RAGE and its ligands: from pathogenesis to therapeutics
Authors:
- 16 September 2020
- journal article
- other
- Published by Taylor & Francis in Critical Reviews in Biochemistry and Molecular Biology
- Vol. 55 (6) , 555-575
Abstract
Receptor for advanced glycation end products (RAGE) is an immunoglobulin-like receptor present on cell surface. RAGE binds to an array of structurally diverse ligands, acts as a pattern recognition receptor (PRR) and is expressed on cells of different origin performing different functions. RAGE ligation leads to the initiation of a cascade of signaling events and is implicated in diseases, such as inflammation, cancer, diabetes, vascular dysfunctions, retinopathy, and neurodegenerative diseases. Because of the significant involvement of RAGE in the progression of numerous diseases, RAGE signaling has been targeted through use of inhibitors and anti-RAGE antibodies as a treatment strategy and therapy. Here in this review, we have summarized the physical and physiological aspects of RAGE biology in mammalian system and the importance of targeting this molecule in the treatment of various RAGE mediated pathologies.Keywords
Funding Information
- Department of Biotechnology, New Delhi (102/IFD/SAN/, BT/, 5/BRB/10/, /)
- Department of Science and Technology, New Delhi (EMR/, /, 32)
- Institute of Life Sciences
This publication has 204 references indexed in Scilit:
- S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancerExperimental Cell Research, 2013
- Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian CellsPLOS ONE, 2013
- S100B protein in tissue development, repair and regenerationWorld Journal of Biological Chemistry, 2013
- Aortic Stiffness, Blood Pressure Progression, and Incident HypertensionJAMA, 2012
- Advanced Glycation End Product Recognition by the Receptor for AGEsStructure, 2011
- S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathwayGlia, 2010
- Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1‐dependent upregulation of sphingosine kinase 1 transcriptionFEBS Letters, 2010
- Carboxylated N‐glycans on RAGE promote S100A12 binding and signalingJournal of Cellular Biochemistry, 2010
- The receptor for advanced glycation endproducts (RAGE) and cardiovascular diseaseExpert Reviews in Molecular Medicine, 2009
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996